This inventor holds 3 USPTO granted patents and 2 published patent applications, plus 1 CIPO patent and 4 EPO patents. Top assignee: Glaxosmithkline Intellectual Property Development Limited. Active years: 2020-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2020-2026
Title: The Innovative Contributions of Andreas Crameri
Introduction
Andreas Crameri is a notable inventor based in Stevenage, GB. He has made significant contributions to the field of oligonucleotide production, holding 3 patents that showcase his innovative processes. His work is particularly relevant in the development of chemically modified oligonucleotides for therapeutic applications.
Latest Patents
Crameri's latest patents focus on novel processes for the production of oligonucleotides. These processes are designed to enhance the production of chemically modified oligonucleotides, which are crucial for therapeutic use. The advancements he has made in this area are expected to have a substantial impact on medical treatments.
Career Highlights
Andreas Crameri is associated with GlaxoSmithKline Intellectual Property Development Limited, where he applies his expertise in the field of biotechnology. His role at the company allows him to contribute to cutting-edge research and development initiatives.
Collaborations
Crameri has worked alongside esteemed colleagues such as Malcolm Leithhead Hill and David Graham Tew. Their collaborative efforts have furthered advancements in the field of oligonucleotide production.
Conclusion
Andreas Crameri's innovative work in oligonucleotide production highlights his importance as an inventor in the biotechnology sector. His contributions are paving the way for future advancements in therapeutic applications.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile